Skip to main navigation Skip to search Skip to main content

26-Week Open Label Extension Study Evaluating the Safety and Tolerability of Flexible doses of Oral Ziprasidone in Children and Adolescents with Bipolar I Disorder

Project: Research

Project Details

StatusFinished
Effective start/end date05/9/06 → 05/8/08

Funding

  • Pfizer Incorporated